Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Baxter
McKesson
AstraZeneca
Express Scripts

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

BETAMETHASONE DIPROPIONATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Betamethasone Dipropionate patents expire, and when can generic versions of Betamethasone Dipropionate launch?

Betamethasone Dipropionate is a drug marketed by Anda Repository, Fougera Pharms, Glenmark Generics, Perrigo Israel, Taro, Acp Nimble, Actavis Mid Atlantic, Perrigo New York, Pharmaderm, Teva, Zydus Pharms, Hi Tech, Teligent Pharma Inc, Alpharma Us Pharms, and Fougera Pharms Inc. and is included in forty-one NDAs.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Drug patent expirations by year for BETAMETHASONE DIPROPIONATE
Drug Prices for BETAMETHASONE DIPROPIONATE

See drug prices for BETAMETHASONE DIPROPIONATE

Drug Sales Revenue Trends for BETAMETHASONE DIPROPIONATE

See drug sales revenues for BETAMETHASONE DIPROPIONATE

Recent Clinical Trials for BETAMETHASONE DIPROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Drug Delivery Solutions Ltd. (part of MC2 Therapeutics)Phase 1
Celgene CorporationPhase 4
Psoriasis Treatment Center of Central New JerseyPhase 4

See all BETAMETHASONE DIPROPIONATE clinical trials

Recent Litigation for BETAMETHASONE DIPROPIONATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Promius Pharma LLC v. Perrigo UK FINCO Limited Partnership2018-05-22

See all BETAMETHASONE DIPROPIONATE litigation

Pharmacology for BETAMETHASONE DIPROPIONATE
Synonyms for BETAMETHASONE DIPROPIONATE
(11-beta,16-beta)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
(11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
(8S,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthr
[2-[(8S,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2-((2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxo -14-propanoyloxytetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-o xoethyl propanoate
5593-20-4
593B204
826Y60901U
9-Fluoro-11.beta.-hydroxy-16.beta.-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl propionate #
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17,21-Dipropionate
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17,21-dipropionate
AB01274713_02
AB01274713-01
AB01275498-01
AB2000220
AC1L2J44
AC1L3T2H
AKOS015969733
AKOS025312304
Alphatrex
AN-14216
API0001696
B3166
BDBM50421892
Beloderm
beta-Methasone 17,21-dipropionate
Betamethasone 17,21-dipropionate
BETAMETHASONE DIPROP
betamethasone dipropionat
Betamethasone Dipropionate (Diprolene)
Betamethasone dipropionate (JP17/USP)
Betamethasone dipropionate [USAN:BAN:JAN]
Betamethasone dipropionate [USAN:USP:JAN]
betamethasone propionate
Betamethasone-17,21-dipropionate
BRD-K58148589-001-03-6
BRN 3638108
C-22966
C28H37FO7
CAS-5593-20-4
CC-24614
CHEBI:31276
CHEMBL1200384
CIWBQSYVNNPZIQ-XYWKZLDCSA-N
component of Alphatrex (Salt/Mix)
component of Betasone (Salt/Mix)
CS-7549
D01637
Diproderm
Diprolene
Diprolene AF
Diprosis
Diprosone
Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene
DSSTox_CID_2672
DSSTox_GSID_22672
DSSTox_RID_76683
DTXSID2022672
EBD2157850
EINECS 227-005-2
en-17-yl propionate
FT-0082786
HMS2090K11
HY-13571
Jsp006667
KS-5303
LS-118474
Maxivate
MFCD00133140
MolPort-002-515-791
MolPort-039-145-111
NCGC00159360-02
NCGC00159443-01
NCGC00159443-02
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)
Psorion
Rinderon DP
Rinderon-DP (TN)
RL03443
S 3440
S-3440
s1688
SC-15701
Sch 11460
Sch-11460
SCHEMBL4566
SCHEMBL7519
Sernivo
Sernivo (TN)
ST024761
Tox21_113343
UNII-826Y60901U
ZINC4212137
Paragraph IV (Patent) Challenges for BETAMETHASONE DIPROPIONATE
Tradename Dosage Ingredient NDA Submissiondate
SERNIVO SPRAY;TOPICAL betamethasone dipropionate 208079 2018-02-15

US Patents and Regulatory Information for BETAMETHASONE DIPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071477-001 Aug 10, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 074304-001 Aug 31, 1995 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo New York BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 072538-001 Jan 31, 1990 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 075373-001 Jun 22, 1999 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Moodys
Medtronic
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.